Osaka, Japan

Masao Hirota

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Otsuka Pharmaceutical Company, Limited, Somalogic, Incorporated. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masao Hirota. Retrieved from https://idiyas.com/inventor/masao-hirota

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Masao Hirota: Innovator in IL-6 Targeting Aptamers

Introduction

Masao Hirota is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of aptamers that target interleukin-6 (IL-6). His work has implications for treating and diagnosing conditions mediated by IL-6, showcasing the potential of aptamer technology in therapeutic applications.

Latest Patents

Hirota holds a patent for "Aptamers that bind to IL-6 and their use in treating or diagnosing IL-6 mediated conditions." This patent includes pharmaceutical compositions comprising IL-6 aptamers and methods for treating conditions using these aptamers. His innovative approach highlights the versatility and effectiveness of aptamers in medical science.

Career Highlights

Throughout his career, Masao Hirota has worked with prominent companies in the pharmaceutical and biotechnology sectors. He has been associated with Somalogic, Incorporated and Otsuka Pharmaceutical Company, Limited. His experience in these organizations has allowed him to advance his research and contribute to significant developments in the field.

Collaborations

Hirota has collaborated with esteemed colleagues, including Shashi Gupta and Daniel J Schneider. These partnerships have fostered a collaborative environment that enhances innovation and drives research forward.

Conclusion

Masao Hirota's work in developing IL-6 targeting aptamers represents a significant advancement in biotechnology. His contributions are paving the way for new therapeutic strategies in treating IL-6 mediated conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…